"Change the OddsTM: Uniting to Improve Cancer Outcomes" is an American Cancer Society initiative with sponsorship funding from Pfizer designed to bridge the gap in cancer care disparities. We are advancing breakthroughs to help patients take control of their futures. With ongoing innovation in precision medicine, we aim for brighter outcomes for patients facing colorectal cancer.
